Showing results (6531-6540 of 10,080) with videos related to

Sort By:
Pageof 1,008
Current Pharmaceutical Design|September 28, 2007
Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disordersSho-ichi Yamagishi, Seiji Ueda, Seiya Okuda
Current Pharmaceutical Design|September 17, 2009
Recent advances on the antiatherogenic effects of HDL-derived proteins and mimetic peptidesMaria P Petraki, Polyxeni T Mantani, Alexandros D Tselepis
Current Pharmaceutical Design|September 17, 2009
EP2300 compounds: focusing on the antiatherosclerotic properties of squalene synthase inhibitorsA Tavridou, V G Manolopoulos
Current Pharmaceutical Design|September 17, 2009
Genomics and the prospects of existing and emerging therapeutics for cardiovascular diseasesM Zaiou, H Benachour, J B Marteau, et al.
Current Pharmaceutical Design|September 16, 2009
Current and future therapeutic strategies for Parkinson's diseaseTiago Fleming Outeiro, Joaquim Ferreira
Current Pharmaceutical Design|September 16, 2009
RNAi applications in therapy development for neurodegenerative diseaseM M Maxwell
Current Pharmaceutical Design|September 17, 2009
Pharmacological therapies for unconjugated hyperbilirubinemiaF J C Cuperus, A M Hafkamp, C V Hulzebos, et al.
Current Pharmaceutical Design|September 17, 2009
Polysulfated/sulfonated compounds for the development of drugs at the crossroad of viral infection and oncogenesisMarco Rusnati, Chiara Urbinati
Current Pharmaceutical Design|September 17, 2009
Dendrimers: a class of polymers in the nanotechnology for the delivery of active pharmaceuticalsAbdus Samad, Md Intakhab Alam, Kinshuk Saxena
Pageof 1,008